When it comes to creating a useful profile for monster growth stocks, the author of today’s article lays out the following criteria: “gangbusters gains, Buy ratings from the Wall Street analyst corps, and considerable upside for the coming year.” With that, he proceeds to highlight three stocks that meet the profile for monster growth, including one that “puts a different…
With their shares having surged by more than 484%, 500% and 275%, respectively, the three stocks highlighted in today’s article are three of the best-performing pharmaceutical stocks over the past year – and despite them having already experienced monster moves higher, it may not be too late to get in on these stocks’ gains. For more on these three pharmaceutical…
Despite a number of anxiety-inducing market routs, stocks have performed quite nicely this year. That impressive performance, however, brings with it some potential problems for investors, including off-balance portfolios and taxes on gains. As the author of today’s article notes, “a lofty market environment presents a lot of potential tax traps, as the appreciated winners in a portfolio that are…